Meridian Financial Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.47M Sell
5,419
-175
-3% -$46K 0.5% 44
2026
Q1
$1.51M Hold
5,594
0.57% 39
2025
Q4
$1.51M Buy
5,594
+62
+1% +$16.5K 0.6% 37
2025
Q3
$1.54M Buy
5,532
+100
+2% +$26.8K 0.64% 34
2025
Q2
$1.43M Buy
5,432
+46
+0.9% +$11.2K 0.67% 35
2025
Q1
$1.25M Buy
5,386
+9
+0.2% +$2.18K 0.64% 32
2024
Q4
$1.23M Sell
5,377
-53
-1% -$12.2K 0.65% 38
2024
Q3
$1.21M Sell
5,430
-2
-0% -$440 0.61% 40
2024
Q2
$1.17M Buy
5,432
+383
+8% +$77.9K 0.69% 35
2024
Q1
$1.02M Buy
5,049
+56
+1% +$12.3K 1.31% 22
2023
Q4
$1.14M Sell
4,993
-141
-3% -$29.6K 1.16% 26
2023
Q3
$1.02M Sell
5,134
-769
-13% -$162K 1.05% 24
2023
Q2
$1.11M Buy
5,903
+202
+4% +$39.2K 0.67% 37
2023
Q1
$1.13M Buy
5,701
+179
+3% +$36.8K 1.28% 19
2022
Q4
$1.2M Buy
5,522
+130
+2% +$25.4K 1.35% 19
2022
Q3
$967K Buy
5,392
+189
+4% +$38.7K 1.37% 18
2022
Q2
$1.11M Buy
5,203
+67
+1% +$14.3K 0.76% 33
2022
Q1
$1.16M Buy
5,136
+94
+2% +$22.1K 1.74% 17
2021
Q4
$1.18M Buy
5,042
+481
+11% +$119K 0.8% 29
2021
Q3
$1.07M Sell
4,561
-14
-0.3% -$3.53K 0.72% 33
2021
Q2
$1.09M Buy
4,575
+152
+3% +$34.6K 0.74% 30
2021
Q1
$988K Buy
4,423
+157
+4% +$31.5K 0.74% 29
2020
Q4
$843K Sell
4,266
-182
-4% -$31.4K 0.65% 32
2020
Q3
$772K Buy
4,448
+311
+8% +$49.3K 0.65% 27
2020
Q2
$668K Buy
4,137
+352
+9% +$48.7K 0.61% 33
2020
Q1
$483K Buy
3,785
+674
+22% +$97.1K 0.52% 37
2019
Q4
$465K Buy
3,111
+195
+7% +$28.2K 0.47% 40
2019
Q3
$412K Buy
2,916
+270
+10% +$39.4K 0.46% 40
2019
Q2
$404K Hold
2,646
0.45% 41
2019
Q1
$328K Buy
+2,646
New +$326K 0.37% 42

Other funds holding LH

Meridian Financial Partners's LH Position: Q2 2026 in Review

Meridian Financial Partners reduced its Labcorp (LH) stake by 3.1% in Q2 2026, selling an estimated $46K and leaving 5,419 shares worth $1.47M. The position accounts for 0.5% of the portfolio, ranked #44.

Meridian Financial Partners first reported a position in LH in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.54M in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Meridian Financial Partners held 5,419 shares of Labcorp worth $1.47M as of Q2 2026.
  • Meridian Financial Partners sold 175 Labcorp shares in Q2 2026, an estimated $46K.
  • Labcorp made up 0.5% of Meridian Financial Partners's portfolio in Q2 2026, its #44 holding.
  • Meridian Financial Partners first reported a position in Labcorp in Q1 2019 and has held it in 30 quarters since.
  • Meridian Financial Partners's Labcorp position peaked at $1.54M in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Meridian Financial Partners's 13F filing for Q2 2026, filed 24 Jul 2026.